Cite
HARVARD Citation
Sandborn, W. et al. (n.d.). OP33 Oral ritlecitinib and brepocitinib in patients with Moderate to Severe Active Ulcerative Colitis: Data from the VIBRATO umbrella study. Journal of Crohn's and colitis. pp. S030-S031. [Online].